SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.

Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.

SK Bioscience will license its vaccine technology to Colombia’s state-owned pharmaceutical firm VECOL and cooperate in establishing a local manufac...